Table 2 shows the concentration of plasma and lipoprotein lipids in RH- and RH+ breast cancer patients and low (Ki-67 ≤ 20%) or high (Ki-67 ≥ 30%) proliferative index. This evidence concerns the gene MKI67 and breast cancer.